Manufactured in facilities with unknownor non-existentquality controls
Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range
With Sterile Water (No Alcohol): Solutions must be used immediately (within 24 hours) as bacteria can proliferate rapidly
(3) Unlike other hormones, naturally occurring Oxytocin has been posited to work via a positive feedback mechanism
Analytical verification is essential for research, as its an important component of quality assurance and reproducibility
A cool, comfortable temperature is also crucial, as the bodys core temperature naturally drops during sleep
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
